The most important number in Sesame’s weight-management offer is not necessarily the lowest one on the page. Success by Sesame advertises a subscription starting at $59 per month with an annual subscription, alongside a $99 month-to-month option. Neither includes medication. For someone comparing GLP-1 services, that means the advertised membership price is only one part of the purchasing decision: the selected clinician, prescription, pharmacy channel, insurance coverage and possible laboratory charges can all affect what gets paid.
This documentary review examines Sesame’s official materials consulted October 19, 2026, rather than a purchased treatment experience. The platform documents a weight-management program connecting patients with independent clinical practices, with video evaluation and continuing care. Its cost disclosures are useful but not fully consistent: one section says monthly billing, another specifies every 28 days, and cancellation instructions differ between the program page and general terms. The practical task is to obtain one written account of the initial charge, subsequent charges and cancellation deadline before enrolling.
At a glance
- Starting subscription price
- From $59 per month with an annual subscription; medication is separate, and individual providers may charge more.Sources: [7]
- Monthly billing discrepancy
- The $99 option is described as billed every month in one section and in advance every 28 days in another.Sources: [7]
- Included laboratory work has limits
- Included testing is through Quest Diagnostics, excluding facilities in AZ, HI, ND, NJ, NY, OK, RI, SD and WY.Sources: [7]
- Medication promotion is conditional
- The advertised $199 introductory injectable Wegovy price applies to qualifying new self-pay patients and specified presentations, not the subscription.
Start with the first charge, not the monthly equivalent
Success by Sesame’s lowest advertised subscription rate is a starting price tied to an annual subscription. The program says annual plans are billed once every 12 months, while six-month and three-month plans are billed once per respective period. Those are advance billing arrangements, not simply invitations to pay the advertised monthly equivalent each month. Sesame also says clinicians set their own prices, so the selected provider’s checkout amount matters more than the headline minimum.
The month-to-month option is listed at $99. Sesame advertises savings relative to that option of $480 per year for the annual plan, $180 per six months for the six-month plan and $60 per three months for the three-month plan. These are Sesame’s stated comparisons, not independently calculated savings. Their usefulness depends on understanding the actual billing calendar and the chosen clinician’s price. A longer billing period also should not be read as a medication supply quantity.
The documents do not supply a personalized checkout statement establishing a particular reader’s first payment. Before committing, request the subscription amount collected immediately, the period it covers and any separate pharmacy or laboratory charge. Our guide to why the first payment can differ from the advertised monthly price explains that distinction. Here, the key point is concrete: a monthly-equivalent annual price and a month-to-month payment are different purchase structures.
| Cost layer | Published terms | What to confirm |
|---|---|---|
| Annual subscription | Starts at $59/month; billed once every 12 months | Selected provider’s upfront charge |
| Month-to-month subscription | $99; described as monthly and elsewhere every 28 days | Exact renewal dates |
| Prescription medication | Not included in the subscription | Product, presentation, pharmacy and price |
| Laboratory work | Included at eligible Quest facilities, with nine state exclusions | Facility eligibility and separate fees |
| Cancellation | Program and general membership instructions differ | Applicable deadline and prepaid-period treatment |
The billing calendar changes the meaning of $99
Sesame’s program page calls the month-to-month plan “billed every month at $99 per month.” Elsewhere on that same page, the advance-billing description says “Billed every 28 days.” Those intervals are not interchangeable. A 28-day charge follows a four-week schedule rather than a fixed calendar-month anniversary. The supplied materials do not resolve which wording governs a particular enrollment, so this is a question for the written order confirmation, not an assumption to make from the plan’s name.
Ask for the first renewal date and the recurring interval in addition to the amount. For prepaid plans, ask when the next three-, six- or twelve-month collection occurs and whether the selected clinician’s rate differs from the advertised starting price. The guide to monthly, four-week and prepaid billing provides a framework for reading those answers. None of Sesame’s appointment or refill descriptions establishes a price lock, and this review does not infer one.
What the care fee buys—and where another bill can appear
The subscription includes telehealth visits, unlimited messaging and ongoing clinical care from a provider the patient chooses. Sesame also describes video follow-up, weight tracking and tools addressing sleep, exercise and eating habits. Its Wegovy page says patients can request refills by messaging their provider rather than booking a separate refill visit. That is a documented access feature, not a guarantee that every message produces a prescription or that a clinician responds within a particular number of hours.
Laboratory coverage is more specific than a broad promise of included testing. The program includes laboratory work completed at Quest Diagnostics facilities except those in Arizona, Hawaii, North Dakota, New Jersey, New York, Oklahoma, Rhode Island, South Dakota and Wyoming. In those excluded states, testing-facility fees are additional to the subscription. The evidence does not establish that testing through another laboratory is included, so a lab order alone should not be mistaken for confirmation that its bill is covered.
The membership does not include medication, and the documents do not settle shipping charges, delivery timing or replacement policies for lost or damaged prescriptions. Nor do they specify a mandatory follow-up frequency or message-response standard. These distinctions make what a program price actually includes especially relevant to Sesame: the service bundle is described, but the total outlay still depends on the prescription, testing location and fulfillment arrangement.
Wegovy prices depend on route, presentation and promotion
Sesame’s Wegovy page describes semaglutide in injectable and oral forms. Its published oral cash prices are $149 for a month’s supply of 1.5 mg or 4 mg tablets and $299 for a month’s supply of 9 mg or 25 mg tablets. These are product-presentation price descriptions, not instructions for selecting or changing treatment. The page directs patients seeking the reduced cash price to ask their clinician to send the prescription to NovoCare pharmacy; the subscription remains additional.
For injectable Wegovy, the program advertises $199 per month for the first two months for new Wegovy patients, then $349 per month. The detailed promotion covers qualifying new self-pay patients in the United States whose prescriber authorizes Wegovy or Ozempic injections, with an offer period of November 17, 2025, through December 31, 2026. The $199 terms specify the first two consecutive treatment months at the 0.25 mg or 0.5 mg presentation. These restrictions should travel with any quoted introductory price.
The Wegovy page excludes people enrolled in federal or state healthcare programs with prescription coverage from that promotion. It also states expressly that the discount applies to medication, not program or service fees. Thus, neither the introductory nor subsequent drug price represents an all-inclusive Success by Sesame payment. These are published commercial terms, not verification that a promotion remains available at checkout or that a particular patient will receive a prescription.
Zepbound shows why the exact dispensing format matters
Sesame describes three injectable Zepbound formats: single-dose pens, multidose KwikPens described as containing a month’s supply, and single-dose vials requiring a separate needle and syringe. Its Zepbound page lists LillyDirect cash prices for vials of $299 per month for the 2.5 mg presentation, $399 for 5 mg and $449 for 7.5, 10, 12.5 or 15 mg. These prices belong to the stated pharmacy channel and format; they are not interchangeable quotes for every Zepbound prescription.
For KwikPens through LillyDirect, the dedicated page lists $299 per month for 2.5 mg, $399 for 5 mg, $499 for 7.5 mg and $699 for 10, 12.5 or 15 mg. The general program page instead lists $398 for 5 mg and $698 for the three highest listed presentations. The dollar differences are small, but the documentary inconsistency is real. Ask which published amount applies rather than treating either page as a personalized pharmacy quote.
The program also names oral Foundayo, identifies its ingredient as orforglipron and makes product-approval claims that this review has not independently verified. It lists Ozempic, Mounjaro, Rybelsus, Victoza and metformin among diabetes medicines that may be used in the weight-management discussion. These listings establish the breadth of Sesame’s advertised menu, not individual suitability or an assured prescription. Sesame specifically says its providers do not prescribe controlled weight-loss medicines.
Insurance can affect the drug bill without paying the subscription
Sesame says it does not bill health insurance for the program and that patients do not need insurance to access it. Separately, it says insurance may cover prescribed weight-loss drugs, with the provider handling prior-authorization paperwork. That assistance is a service feature, not a promise of approval or a particular copayment. NIDDK likewise notes that some plans cover weight-management medicines and others do not; an individual drug benefit needs confirmation with the insurer.
A material eligibility tension remains. Although the marketing describes access without regard to insurance, the supplied telemedicine terms require users to certify that they are not beneficiaries of a federal healthcare program, naming Medicare, Medicaid and TRICARE as examples. That provision is separate from the manufacturer promotion’s government-insurance exclusion. A beneficiary should seek a clear answer about service eligibility before paying, rather than assume that a willingness to self-pay resolves the contractual restriction.
Sesame also says most services within the subscription may qualify for HSA or FSA reimbursement and offers an itemized bill through support@sesamecare.com. That is not confirmation that every charge is reimbursable. Patients can request a breakdown separating the subscription, medication and testing, then verify treatment of those charges with the relevant account administrator. The supplied evidence does not establish an individual reimbursement outcome or a tax conclusion.
Follow the responsibility chain before paying
Sesame identifies itself as Sesame, Inc., operating through its website and mobile applications. Its homepage says affiliated practices are independently owned and operated by licensed clinicians. Enrollment starts with a questionnaire and provider selection, followed by a video consultation about medical history and goals; the clinician may order testing if metabolic information is needed. General terms require adulthood, service availability in the patient’s state and physical presence in the same state as the shipping address during consultation.
The program describes ideal medication candidates as adults with BMI of at least 30, or at least 27 with weight-related conditions. It also lists restrictions involving pancreatitis history, personal or family history of medullary thyroid cancer, MEN2 and type 1 diabetes. Those are Sesame’s published screening statements, not a complete individualized assessment. Its terms say prescribing depends on the provider’s judgment and medical necessity, with no guarantee of a prescription. Payment therefore purchases evaluation and care, not assured medication access.
If prescribed, Sesame advertises same-day pickup at a preferred local pharmacy or home delivery, while its terms name Truepill as a delivery partner and state that Sesame is not a pharmacy. Same-day pickup language does not establish stock availability or a home-arrival deadline. Shipping fees and cold-chain procedures remain undocumented here. For injectable GLP-1 products arriving warm or insufficiently refrigerated, FDA explicitly advises not using the product and contacting the provider or dispensing pharmacy.
Cancellation is not the same as getting money back
The program page offers a full refund when cancellation occurs at least three hours before the initial visit starts. It says the first month is not refundable once that visit has occurred. For ongoing subscriptions, it describes self-cancellation at any point, provided cancellation happens before the next billing cycle to avoid future charges, and says fees for previous months are not refundable. Those provisions distinguish a narrowly timed initial refund from stopping later renewals.
General membership terms give a different operational instruction: request cancellation by emailing support@sesamecare.com or calling +1 (877) 947-6411 at least 48 hours before renewal processing. They allow continued access through the paid term but deny a prorated refund of the recurring fee for that term. The supplied documents do not clearly explain every refund consequence for prepaid three-, six- or twelve-month plans, and the supplied terms contain an omitted intermediate section.
The prudent preparation is to obtain the applicable deadline and prepaid-period policy in writing, preserve the cancellation confirmation and avoid relying on last-minute self-service cancellation alone. Our guide to cancellation and refunds explains why stopping a future charge does not establish a right to recover an earlier one. Sesame’s differing instructions do not prove that cancellation is unavailable; they do make the route, timing and financial effect important unresolved enrollment questions.
Questions & answers
Does Sesame’s $59 price include a GLP-1 prescription?
No. The starting $59 monthly-equivalent price requires an annual subscription and covers the care service, not medication. The annual plan is described as billed once every 12 months, and clinicians may charge more than the advertised starting rate. A prescription is also not guaranteed: Sesame’s terms leave prescribing to the clinician based on medical necessity.
Is the $99 plan charged monthly or every four weeks?
The supplied program page uses both descriptions. One section says every month, while another says advance billing every 28 days. Request the actual renewal calendar before enrollment and retain the answer with your order confirmation. This review cannot resolve that contradiction or treat a four-week interval as equivalent to a calendar month.
Will my laboratory testing be included?
The documented inclusion is for testing at Quest Diagnostics facilities, excluding those in AZ, HI, ND, NJ, NY, OK, RI, SD and WY. In those states, laboratory fees are additional. Ask the clinician where an order will be performed and obtain the facility’s charge information before testing; an included clinical consultation does not make every laboratory location included.
Can I use insurance for medication while paying Sesame myself?
Sesame describes that arrangement and says its provider helps with prior authorization, but coverage is not assured. There is also a separate contractual issue: the telemedicine terms require certification that the user is not a federal healthcare-program beneficiary. Anyone affected should clarify eligibility before purchasing, rather than assume the program’s self-pay structure overrides that provision.
Must I use Sesame’s delivery pharmacy?
The program advertises local-pharmacy pickup or home delivery, and general terms identify Truepill as a partner. However, particular cash prices have channel restrictions: Sesame directs patients to NovoCare for reduced-price Wegovy and quotes LillyDirect prices for specified Zepbound formats. Confirm the pharmacy attached to your price; the materials do not establish universal availability across pharmacies.
What happens if I cancel after my first appointment?
The program says the first month is not refundable once the initial visit occurs. General membership terms deny prorated refunds for the current paid term while allowing access until that term ends. Because cancellation routes and deadlines differ across the documents, request written clarification, particularly for a prepaid plan, and account for the general terms’ minimum 48-hour notice before renewal processing.
Our assessment
Success by Sesame documents a recognizable care package: clinician selection, video evaluation, messaging, ongoing follow-up and conditionally included Quest testing. Its separation of subscription and medication charges is explicit, and its drug pages provide useful presentation-specific cash prices. The principal cost weakness is not an absence of numbers; it is that some numbers and operating terms do not align across the materials. Before purchasing, obtain the selected clinician’s upfront fee, exact renewal interval, pharmacy-specific drug quote, laboratory exclusions and applicable cancellation instructions in one written record. The annual starting rate may be relevant to someone comfortable with advance billing, but it is not an all-inclusive treatment price. The $99 option needs calendar clarification, and prepaid cancellation consequences need a clearer answer. Those unresolved details are material enough to settle before payment, without negating the services Sesame does document.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- Sesame / Success by Sesame — official website ↗
- Sesame / Success by Sesame — terms of service ↗
- Sesame / Success by Sesame — medication/zepbound ↗
- Sesame / Success by Sesame — medication/wegovy ↗
- Sesame / Success by Sesame — service/online weight loss program ↗